These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17062205)

  • 21. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
    Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
    J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ST-segment elevation during levosimendan infusion.
    Barillà F; Giordano F; Jacomelli I; Pellicano M; Dominici T
    J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):454-6. PubMed ID: 22673026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and effectiveness of levosimendan in patients with predominant right heart failure.
    Poelzl G; Zwick RH; Grander W; Metzler B; Jonetzko P; Frick M; Ulmer H; Pachinger O; Roithinger FX
    Herz; 2008 Jul; 33(5):368-73. PubMed ID: 18773157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics and pharmacokinetics of oral levosimendan and its metabolites in patients with severe congestive heart failure: a dosing interval study.
    Põder P; Eha J; Sundberg S; Antila S; Heinpalu M; Loogna I; Planken U; Rantanen S; Lehtonen L
    J Clin Pharmacol; 2004 Oct; 44(10):1143-50. PubMed ID: 15342615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
    Metzsch C; Liao Q; Steen S; Algotsson L
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
    Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M
    J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction.
    Jia Z; Guo M; Zhang YQ; Liang HQ; Zhang LY; Song Y
    Cardiology; 2014; 128(2):195-201. PubMed ID: 24751462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure.
    Kivikko M; Antila S; Eha J; Lehtonen L; Pentikäinen PJ
    J Clin Pharmacol; 2002 Jan; 42(1):43-51. PubMed ID: 11808823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure.
    Ikonomidis I; Parissis JT; Paraskevaidis I; Kourea K; Bistola V; Lekakis J; Filippatos G; Kremastinos DT
    Eur J Heart Fail; 2007 Dec; 9(12):1172-7. PubMed ID: 18062901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study.
    Bravo MC; López P; Cabañas F; Pérez-Rodríguez J; Pérez-Fernández E; Quero J; Pellicer A
    Neonatology; 2011; 99(3):217-23. PubMed ID: 20881438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.
    Papanikolaou J; Tsolaki V; Makris D; Zakynthinos E
    Int J Cardiol; 2014 Oct; 176(3):1435-7. PubMed ID: 25147072
    [No Abstract]   [Full Text] [Related]  

  • 34. Levosimendan for low cardiac output: a pediatric experience.
    Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
    J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic preoperative levosimendan administration in heart failure patients undergoing elective non-cardiac surgery: a preliminary report.
    Katsaragakis S; Kapralou A; Drimousis P; Markogiannakis H; Larentzakis A; Kofinas G; Misthos P; Filis K; Theodorou D
    Hellenic J Cardiol; 2009; 50(3):185-92. PubMed ID: 19465359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inotropic agents in advanced heart failure: repetita iuvant?
    De Luca L
    Int J Cardiol; 2014 Sep; 176(1):6-7. PubMed ID: 25065330
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
    Nieminen MS; Akkila J; Hasenfuss G; Kleber FX; Lehtonen LA; Mitrovic V; Nyquist O; Remme WJ
    J Am Coll Cardiol; 2000 Nov; 36(6):1903-12. PubMed ID: 11092663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
    Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan. A promising future drug for refractory cardiac failure in children?
    Kushwah S; Kumar A; Sahana KS
    Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S57-60. PubMed ID: 27056655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
    Tasouli A; Papadopoulos K; Antoniou T; Kriaras I; Stavridis G; Degiannis D; Geroulanos S
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):629-33. PubMed ID: 17702589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.